In this issue:
Leukaemia selection
Prognostic impact of minimal residual disease in CBFB-MYH11-positive AML
Costs of voriconazole vs. posaconazole in AML
Addition of lomustine in elderly AML patients
Lymphoma selection
T-cell-depleted, reduced-intensity transplantation followed by DLIs in FL
18 F-FDG PET/CT in FL
Consolidation radiotherapy in advanced Hodgkin’s lymphoma
Siltuximab for Castleman’s disease
Consolidative radiotherapy in DLBCL treated with R-CHOP
Prognostic value of cytogenetic aberrations in SMZL
Please login below to download this issue (PDF)